519 672 2121
Close mobile menu
Showing 201 - 210 of 514

Actos

Actos (pioglitazone hydrochloride) is an oral anti-diabetic drug manufactured by Takeda and prescribed to decrease blood sugar levels in patients with type 2 diabetes. A Canada-wide settlement has been reached in five proposed class actions relating to the prescription drugs ACTOS®, APO-Pioglitazone and SANDOZ-Pioglitazone. Hearings were held in the supervising Courts in Québec and Ontario...

Continue reading the post titled Actos

Avandia

A Canada-wide settlement was reached and approved on June 13, 2019 by the Supreme Court of Nova Scotia. The Claims Deadline for filing a claim under the settlement was on July 15, 2020. The settlement has now concluded and no further claims are being accepted. Avandia, a drug used to treat diabetes, is associated with...

Continue reading the post titled Avandia
Published on: 20 Jul 2010 By (Dianne Saxe)

GHG reductions: are we getting better?

The federal government has quietly admitted that its greenhouse gas emissions (GHG) reduction efforts are having little effect. The Harper Conservatives won’t comply with the action plan portion of the Kyoto Protocol Implementation Act, 2007 , but they do  file the reports to Parliament that the KPIA requires. As a result, they have been forced...

Continue reading the post titled GHG reductions: are we getting better?
Published on: 17 Apr 2009 By

Spring Roundup of citizen scientists

One way to make the impact of climate change more real is to participate in gathering scientific data about it. Everyone (including children) can participate in NatureWatch, a series of volunteer monitoring programs sponsored by the Environment Canada, Nature Canada, the Trillium Foundation, Ontario Parks, among others. By providing data that fills geographical gaps in...

Continue reading the post titled Spring Roundup of citizen scientists
Published on: 9 Aug 2023 By

Bladder drug Elmiron – linked to vision loss, macular degeneration – still among top non-patented drugs in Canada per 2023 report

Elmiron, a medication prescribed for bladder issues that has been linked to a unique form of macular degeneration causing vision loss, continues to rank among the top publicly funded non-patented drugs in Canada, according to a government report on public drug plan expenditures published earlier this year. The latest edition of Canada’s “Annual Public Drug...

Continue reading the post titled Bladder drug Elmiron – linked to vision loss, macular degeneration – still among top non-patented drugs in Canada per 2023 report
Published on: 19 May 2011 By (Dianne Saxe)

Pharmaceuticals, drinking water, and liability

The better our detection ability becomes, the more things we find in the water. One important group of those things is pharmaceuticals and their metabolites. Pharmaceuticals are specifically designed to affect the bodies, brains and behaviour of humans and other animals, at comparatively low concentrations. Some pharmaceuticals have synergistic effects with other pharmaceuticals, or with...

Continue reading the post titled Pharmaceuticals, drinking water, and liability
Published on: 10 Jan 2011 By (Dianne Saxe)

US toxics overhaul

Most modern toxic substances control laws are based on the 1976 US Toxic Substances Control Act, 15 U.S.C. §2601 et seq. (TSCA).  It provides the US Environmental Protection Agency with authority to require reporting, record-keeping and testing requirements, and restrictions relating to certain kinds of chemical substances and/or mixtures,  such as polychlorinated biphenyls (PCBs), asbestos,...

Continue reading the post titled US toxics overhaul